rare disease data center
Accelerate Rare Disease Data Center vs NIH: Real Difference?
Accelerate Rare Disease Data Center vs NIH: Real Difference? 30% of ARC grant projects have moved to early clinical trials, far outpacing the typical rare disease timeline. This speed reflects the combined power of a unified data platform and adaptive funding, while NIH-funded oncology studies show a slower 12% acceleration.